NASDAQ:VRAYViewray Stock Price, Forecast & News

Viewray's stock was trading at $1.69 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, VRAY shares have increased by 91.7% and is now trading at $3.24.
View which stocks have been most impacted by COVID-19.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viewray in the last year. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Viewray.

Viewray is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Viewray.

Viewray Inc (NASDAQ:VRAY) announced its earnings results on Thursday, July, 30th. The company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.16) by $0.02. The company had revenue of $14.22 million for the quarter, compared to the consensus estimate of $5.81 million. Viewray had a negative return on equity of 63.41% and a negative net margin of 166.74%.
View Viewray's earnings history.

9 Wall Street analysts have issued 1 year price objectives for Viewray's stock. Their forecasts range from $2.00 to $8.00. On average, they anticipate Viewray's stock price to reach $4.56 in the next year. This suggests a possible upside of 40.8% from the stock's current price.
View analysts' price targets for Viewray.

Media stories about VRAY stock have trended extremely negative this week, InfoTrie reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Viewray earned a news impact score of -4.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days.
View the latest news about Viewray.

Some companies that are related to Viewray include InMode (INMD), BioLife Solutions (BLFS), Zynex (ZYXI), Natus Medical (NTUS), AxoGen (AXGN), TransMedics Group (TMDX), Semler Scientific (SMLR), Stereotaxis (STXS), Cutera (CUTR), BioSig Technologies (BSGM), Fonar (FONR), Edap Tms (EDAP), Soleno Therapeutics (SLNO), electroCore (ECOR) and Fc Global Realty (FCRE).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Viewray investors own include Alibaba Group (BABA), Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ), Amarin (AMRN), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Verastem (VSTM), Viking Therapeutics (VKTX), AbbVie (ABBV) and Accuray (ARAY).

(VRAY) raised $52 million in an initial public offering on the week of April 6th 2015. The company issued 4,000,000 shares at $12.00-$14.00 per share. Cowen and Company and Stifel served as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

Viewray trades on the NASDAQ under the ticker symbol "VRAY."

Viewray's stock is owned by many different institutional and retail investors. Top institutional shareholders include Candriam Luxembourg S.C.A. (0.62%), Rhenman & Partners Asset Management AB (0.53%), Essex Investment Management Co. LLC (0.34%), Bank of New York Mellon Corp (0.33%), King Luther Capital Management Corp (0.19%) and California Public Employees Retirement System (0.15%). Company insiders that own Viewray stock include International Ltd Fosun, James F Dempsey, Orbimed Advisors Llc, Scott William Drake and Shahriar Matin.
View institutional ownership trends for Viewray.

VRAY stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Ieq Capital LLC, Rhenman & Partners Asset Management AB, King Luther Capital Management Corp, Essex Investment Management Co. LLC, Swiss National Bank, and Arizona State Retirement System.
View insider buying and selling activity for Viewray.

VRAY stock was bought by a variety of institutional investors in the last quarter, including Candriam Luxembourg S.C.A., California Public Employees Retirement System, Bank of New York Mellon Corp, UBS Group AG, Hodges Capital Management Inc., New York State Common Retirement Fund, Principal Financial Group Inc., and Virtu Financial LLC. Company insiders that have bought Viewray stock in the last two years include International Ltd Fosun, Scott William Drake, and Shahriar Matin.
View insider buying and selling activity for Viewray.

Shares of VRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of VRAY stock can currently be purchased for approximately $3.24.

Viewray has a market capitalization of $479.34 million and generates $87.78 million in revenue each year. The company earns $-120,200,000.00 in net income (profit) each year or ($1.18) on an earnings per share basis.

The official website for Viewray is www.viewray.com.

Viewray's mailing address is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. The company can be reached via phone at 440-703-3210 or via email at [email protected]